Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

User Avatar Image
(273)
•••
  • partystockerX
Post by partystockeron Feb 01, 2022 4:56pm
118 Views
Post# 34386981

$ASEP hires two new high-profile members for advisory board

$ASEP hires two new high-profile members for advisory board

Asep Medical Holdings has announced the addition of two high-profile members to its advisory board. 


Dr. Christopher Mow and Patrick McBride bring decades of both public/private/corporate healthcare experience and financial experience to the table. Notably, McBride has raised in excess of $10 billion of growth capital in his 15-year tenure. 


Additionally, $ASEP has retained two agencies to assist with its IR and digital advertising campaigns. Both Hybrid Financial Ltd. and Native Ads Inc. will assist $ASEP in creating a heightened awareness of $ASEP.CN and its brand in the market. 


$ASEP currently has a massive opportunity to seize a share of the growing $40.7 billion dollars global anti-biotic market. I think improving the company’s visibility is a great step as the company continues to develop its novel diagnostic and therapy technologies. I hope to hear progress announcements soon. 


$ASEP is currently trading at $.395 and the company is valued at an MCAP of $22.17 million. 


https://ceo.ca/@newswire/asep-medical-holdings-inc-announces-additions-to-its

 
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities